DeepSeek's claim of $6m AI training costs is misleading; it excludes significant CAPEX, R&D, and operational expenses, supported by High Flyer's extensive ... demand on, for example, Azure ...

This year's edition presents a broad mix of theme-based stock picks, momentum-driven high-flyers and beaten-up ... on pallets instead of on shelves, for example). Similar hard discount grocers ...

Choose from Flyer Layouts Drawing stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

Bio-Techne beat second-quarter profit and revenue estimates on Wednesday, helped by growth in its protein sciences unit that makes products to develop therapies ...

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company focused on innovative drug delivery technologies, ...

J&J is exploring the sale of Cerenovus, a stroke care business, in a deal potentially worth $1 billion to $1.5 billion. The company spent over $30 billion on medtech acquisitions in the past three ...

Analyst Justin Zelin of BTIG maintained a Buy rating on Legend Biotech (LEGN – Research Report), retaining the price target of $91.00. Justin Zelin has given his Buy rating due to a combination ...

AbbVie (ABBV) stock was one of the top gainers in the S&P 500 Friday morning as the biotech firm posted better-than-expected sales and gave strong guidance on higher demand for two of its drugs to ...

AstraZeneca Q4 revenue rose 18% to $14.89 billion, surpassing estimates, with oncology sales up 27% to $6.34 billion. FY25 guidance projects high single-digit revenue growth and low double-digit ...